Capacity Expansion And Biotechnological Processes Will Strengthen API Supply

Shared on01 May 25
Fair value Increased 3.70%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.34%

AnalystConsensusTarget has decreased revenue growth from -1.0% to -0.8%.

Shared on09 Apr 25
Fair value Increased 2.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 4.28%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.